Russian invasion of Ukraine could have multimillion-dollar impact on Novo Nordisk
1 percent of Novo Nordisk’s total sales could potentially be impacted by the war in Ukraine, said Novo exec Maziar Mike Doustdar at the company’s capital markets day.
by CHRISTOPHER DUE KARLSSON, translated by daniel pedersen
It’s not yet fully known what Russia’s invasion of neighboring country Ukraine will mean for Denmark’s biggest pharmaceutical firm, Novo Nordisk.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk donates two months' worth of insulin to Ukraine
For subscribers
